Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib

NCT01694277 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

258

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG: Masitinib
DRUG: Sunitinib

Sponsor

AB Science